CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Basilea Expects 2026 Operating Profit Of CHF 115 Mln

By Reuters News

Oct 27 (Reuters) - BASILEA PHARMACEUTICA AG, ALLSCHWIL BSLN.S:

  • RAISES FULL-YEAR GUIDANCE 2026 AND FINANCIAL TARGET FOR “AGENDA 2030” AND PROVIDES UPDATES ON LATE-STAGE CLINICAL PROGRAMS

  • 2026 OPERATING PROFIT EXPECTED TO REACH CHF 115 MILLION

  • RAISES FINANCIAL GUIDANCE FOR FY2026 AND CASH FLOW TARGET FOR 2026-2030

  • FY2026 RESEARCH AND DEVELOPMENT EXPENSES GUIDANCE CHF 125 MILLION; OPERATING PROFIT GUIDANCE CHF 115 MILLION

  • OUTLOOK 2026: EXPECTS TOTAL REVENUE AROUND CHF 310 MILLION

Further company coverage: BSLN.S

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk